SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-18-006053
Filing Date
2018-12-18
Accepted
2018-12-18 17:00:14
Documents
2
Period of Report
2018-12-13
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ipix_8k.htm 8-K 14077
2 LETTER FROM BAKER TILLY VIRCHOW KRAUSE, LLP ipix_ex161.htm EX-16.1 1374
  Complete submission text file 0001477932-18-006053.txt   16781
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37357 | Film No.: 181241142
SIC: 2834 Pharmaceutical Preparations